LOX and neoplasm: Since catalytically active LOX, whose levels could plausibly differ between vascular beds, may be able to act as a chemoattractant and a modulator of adhesion and the invasiveness of tumor cells [17], [20], we investigated whether BAPN administration would alter the anatomical pattern of metastases.